Bacterial meningitis primary prevention: Difference between revisions

	Meningitis main page
	Bacterial meningitis Microchapters
Home
Patient Information
Overview
Historical Perspective
Classification
Pathophysiology
Causes
Differentiating Meningitis from other Diseases
Epidemiology and Demographics
Risk Factors
Natural History, Complications and Prognosis
Diagnosis
History and Symptoms
Physical Examination
Laboratory Findings
CT
MRI
Lumbar Puncture
Other Imaging Findings
Other Diagnostic Studies
Treatment
Medical Therapy
Surgery
Primary Prevention
Secondary Prevention

Revision as of 15:24, 5 January 2017

Editor-In-Chief: C. Michael Gibson, M.S., M.D. [1]; Associate Editor(s)-in-Chief: Aysha Anwar, M.B.B.S [2]

Primary preventive measures to prevent bacterial meningitis include the following

There are three types of vaccination available for prevention of bacterial meningitis from three bacterial agents. These include:


Type of Vaccination	Recommendations
Vaccinations
Pneumococcal	Pneumococcal conjugate vaccine Children under 2 years of age Older people >65 years of age Individuals 2 to 65 years of with medical conditions such as patients with CKD, cochlear implants, asplenia Pneumococcal polysaccharide vaccine All adults 65 years or older People 2 to 65 years with certain medical conditions such as diabetes and chronic heart, lung or liver disease Adults 19 to 64 years who smoke cigarettes
Meningococcal	Children and adolescents age 11 through 18 Military recruits College students living in dorms Splenectomy or splenic damage Person having complement deficiency People travelling to endemic areas such as Africa
Hemophilus influenza type b (Hib)


Preventive strategy	Recommendations
Other preventive measures
Avoidance of risk factors
Droplet precaution
Chemoprophylaxis	Chemopropylaxis with rifampin 600 mg or ciprofloxacin All household members Roomates or intimate contacts Child care workers People directly exposed to patient's respiratory or oral secretions Airline travelers seated close to affected person > 8 hours

@@ Line 64: / Line 64: @@
 | style="padding: 5px 5px; background: #DCDCDC;" |'''Chemoprophylaxis'''
 | style="padding: 5px 5px; background: #F5F5F5;" |
-*
+*Chemopropylaxis with rifampin 600 mg or ciprofloxacin
-*
+*All household members
-*
+*Roomates or intimate contacts
+*Child care workers
+*People directly exposed to patient's respiratory or oral secretions
+*Airline travelers seated close to affected person > 8 hours
 |-
 |}